Australia markets open in 6 hours 36 minutes

Propanc Biopharma, Inc. (PPCB)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00110.0000 (0.00%)
As of 01:01PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
201.98
247.919
256.052
230.956
179.987
Selling general and administrative
1,249
1,529
1,735
1,581
3,314
Total operating expenses
1,451
1,777
1,991
1,812
3,494
Operating income or loss
-1,451
-1,777
-1,991
-1,812
-3,494
Interest expense
714.146
532.821
568.798
449.457
1,748
Total other income/expenses net
-457.053
-480.977
-159.009
122.237
366.244
Income before tax
-2,622
-2,790
-2,713
-2,139
-4,875
Income tax expense
-129.14
-129.841
-54.977
-113.415
-134.728
Income from continuing operations
-2,493
-2,661
-2,658
-2,026
-4,741
Net income
-2,493
-2,661
-2,658
-2,026
-4,741
Net income available to common shareholders
-2,728
-3,127
-3,358
-2,418
-4,741
Basic EPS
0.29
-1.80
-49.23
-800.00
-18.37k
Diluted EPS
0.29
-1.80
-49.23
-800.00
-18.37k
Basic average shares
4,368
1,739
68.219
3.032
0.258
Diluted average shares
4,368
1,739
68.219
3.032
0.258